Qingdao Vland Biotech INC. (SHA:603739)
China · Delayed Price · Currency is CNY 15.64
+0.01 (0.06%)
At close: Feb 13, 2026
SHA:603739 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 83.57 | 62.64 | 80.71 | 69.84 | 132.57 | 108.98 |
Depreciation & Amortization | 110.41 | 110.41 | 73.79 | 65.71 | 51.7 | 42.87 |
Other Amortization | 1.78 | 1.78 | 0.49 | 0.95 | 0.2 | 0.22 |
Loss (Gain) From Sale of Assets | 0.6 | 0.6 | -0 | 0.35 | -0.05 | -0.14 |
Asset Writedown & Restructuring Costs | 0.55 | 0.55 | 3 | - | 1.98 | 4.01 |
Loss (Gain) From Sale of Investments | -7.08 | -7.08 | -15.64 | -3.48 | -7.63 | 0.45 |
Provision & Write-off of Bad Debts | 3.92 | 3.92 | 12.98 | 11.87 | 7.82 | 5.96 |
Other Operating Activities | 6.19 | 56.57 | 41.5 | 29.97 | 19.65 | 15.1 |
Change in Accounts Receivable | -40.88 | -40.88 | -36.65 | -110.01 | -91.03 | -32.33 |
Change in Inventory | 13.84 | 13.84 | -35.62 | -19.16 | -33.19 | -21.58 |
Change in Accounts Payable | -6.46 | -6.46 | 33.15 | 51.03 | 10.24 | 47.55 |
Operating Cash Flow | 165.96 | 195.41 | 153.59 | 95.31 | 89.51 | 173 |
Operating Cash Flow Growth | -3.27% | 27.22% | 61.16% | 6.47% | -48.26% | 164.82% |
Capital Expenditures | -85.45 | -104.72 | -215.64 | -342.02 | -493.58 | -211.83 |
Sale of Property, Plant & Equipment | 2.46 | 2.08 | 0.93 | 0.11 | 0.11 | 0.31 |
Cash Acquisitions | - | -18.36 | -16.84 | -0.91 | -45.96 | - |
Divestitures | 0.41 | 0.41 | -0.2 | - | - | - |
Investment in Securities | 81.87 | 65.43 | -75.81 | -103.12 | -75.43 | 82.05 |
Other Investing Activities | -45.17 | 12.71 | 10.91 | 17.77 | 8.13 | 33.74 |
Investing Cash Flow | -45.89 | -42.46 | -296.66 | -428.17 | -606.73 | -95.73 |
Long-Term Debt Issued | - | 842.68 | 661.27 | 489.55 | 360 | 216.18 |
Total Debt Issued | 798.29 | 842.68 | 661.27 | 489.55 | 360 | 216.18 |
Long-Term Debt Repaid | - | -915.25 | -461.16 | -203.7 | -192.44 | -179.9 |
Total Debt Repaid | -957.98 | -915.25 | -461.16 | -203.7 | -192.44 | -179.9 |
Net Debt Issued (Repaid) | -159.69 | -72.57 | 200.11 | 285.85 | 167.56 | 36.28 |
Issuance of Common Stock | - | - | 7.76 | 4.74 | 498.82 | - |
Common Dividends Paid | -51.66 | -55.23 | -39.77 | -52.77 | -37.79 | -32.55 |
Other Financing Activities | 25.4 | -13.67 | -11.74 | -10.1 | -48.03 | -3.87 |
Financing Cash Flow | -185.96 | -141.47 | 156.36 | 227.72 | 580.56 | -0.14 |
Foreign Exchange Rate Adjustments | 0.13 | 0.13 | 0.73 | 1.07 | -1.47 | -1.23 |
Net Cash Flow | -65.76 | 11.61 | 14.03 | -104.07 | 61.87 | 75.9 |
Free Cash Flow | 80.51 | 90.69 | -62.05 | -246.72 | -404.06 | -38.83 |
Free Cash Flow Margin | 5.79% | 6.87% | -5.18% | -21.21% | -35.11% | -4.04% |
Free Cash Flow Per Share | 0.32 | 0.36 | -0.25 | -0.95 | -1.65 | -0.17 |
Cash Income Tax Paid | 88.11 | 83.84 | 80.82 | 44.62 | 58.15 | 47.79 |
Levered Free Cash Flow | 9.25 | 10.14 | 20.05 | -241.42 | -418.19 | -87.8 |
Unlevered Free Cash Flow | 22.35 | 23.82 | 29.56 | -236.94 | -416.86 | -86.69 |
Change in Working Capital | -33.99 | -33.99 | -43.24 | -79.9 | -116.74 | -4.45 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.